Quinolone-resistant and CTX-M-15-producing Escherichia coli isolates belonging to clone ST131 have been reported in the community. This study was designed to identify these E. coli isolates in the stools of 332 independent healthy subjects living in the area of Paris, France. Stools were plated on media without antibiotics, in order to obtain the dominant (Dm) fecal E. coli strain, and with nalidixic acid (NAL) and cefotaxime. Quinolone susceptibility, phylogenetic groups, and molecular profiles, including multilocus sequence types (ST), were determined for all NAL-resistant (NAL-R) isolates. Groups were also determined for the Dm strains from participants with NAL-R isolates and from a subgroup without NAL-R isolates. All B2 isolates were typed; pulsed-field gel electrophoresis was performed for the ST131 isolates, and the results were compared with those for intercontinental clone ST131. Two participants (0.6%) had extended-spectrum -lactamase-producing (SHV-2, TEM-52) fecal E. coli isolates, and 51 (15%) had NAL-R isolates; 51% of NAL-R isolates belonged to phylogenetic group A, 31% to group D, 16% to group B2, and 2% to group B1. The Dm strain was NAL-R in 3.3% of the 332 subjects. Forty-nine percent of the NAL-R isolates belonged to clones: ST10 and ST606 for group A isolates, ST117 and ST393 for group D isolates. Of all B2 isolates studied from 100 subjects (8 NAL-R strains; 19 NAL-susceptible dominant strains), 52% belonged to three clones: ST131 (n ؍ 7), ST95 (n ؍ 4), and ST141 (n ؍ 3). This is the first study to show the presence of fecal E. coli isolates of clone ST131 in 7% of independent healthy subjects not colonized by CTX-M-15-producing isolates.Escherichia coli, a universal commensal of humans and several animal species, is also one of the most common enterobacterial species to cause extraintestinal infections in their hosts (30). According to several recent publications, E. coli isolates producing extended-spectrum -lactamases (ESBL) of the CTX-M type have emerged in the community in numerous countries (25)(26)(27)(28). These isolates resist extended-spectrum cephalosporins because of CTX-M production and are often resistant to other antibiotic families, in particular fluoroquinolones and/or cotrimoxazole (28). This pattern of multidrug resistance is dangerous for the treatment of communityacquired infections, because these drugs are often prescribed by general practitioners, especially for urinary tract infections (UTIs). Moreover, a clonal group producing CTX-M-15 has been identified among fluoroquinolone-resistant and CTX-M-producing E. coli isolates (phylogenetic group B2, O25:H4, ST131) in both inpatients and outpatients all over the world, strongly suggesting that this clone can disseminate widely (20).Because of these recent data and because the main reservoir of extraintestinal pathogenic E. coli isolates is the human digestive tract (8), the aim of this study was to identify CTX-M-15-producing E. coli isolates and E. coli clone ST131 in the guts of healthy adult subjects living ...